1. Reversible Pisa syndrome (pleurothotonus) due to the cholinesterase inhibitor galantamine: case report.
- Author
-
Cossu G, Melis M, Melis G, Maccioni E, Putzu V, Catte O, and Putzu PF
- Subjects
- Aged, Alzheimer Disease diagnosis, Botulinum Toxins, Type A therapeutic use, Cholinesterase Inhibitors therapeutic use, Cognition Disorders diagnosis, Cognition Disorders drug therapy, Dystonia drug therapy, Dystonia physiopathology, Female, Galantamine therapeutic use, Humans, Neuromuscular Agents therapeutic use, Neuropsychological Tests, Severity of Illness Index, Syndrome, Alzheimer Disease drug therapy, Cholinesterase Inhibitors adverse effects, Dystonia chemically induced, Galantamine adverse effects
- Abstract
We report on a case of reversible Pisa syndrome developed after treatment with galantamine in a patient with Alzheimer's disease without previous exposure to neuroleptic or other cholinesterase inhibitors. Complete and persistent resolution of the syndrome was achieved several weeks after botulinum toxin type-A injection., ((c) 2004 Movement Disorder Society.)
- Published
- 2004
- Full Text
- View/download PDF